Abstract PD9-06: Evaluation of the Predicted Sensitivity to Endocrine Therapy (SET2,3 Index) and the 21-Gene Breast Recurrence Score® Assay in Node-Positive Postmenopausal Breast Cancer: Results from an Analysis in the SWOG S8814 Trial
Cancer Research(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined